Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions
Publication
, Journal Article
Villa, LL; Perez, G; Kjaer, SK; Paavonen, J; Lehtinen, M; Muñoz, N; Sigurdsson, K; Hernandez-Avila, M; Skjeldestad, FE; Thoresen, S; García, P ...
Published in: Obstetrical and Gynecological Survey
September 1, 2007
Duke Scholars
Published In
Obstetrical and Gynecological Survey
DOI
ISSN
0029-7828
Publication Date
September 1, 2007
Volume
62
Issue
9
Start / End Page
578 / 579
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine
Citation
APA
Chicago
ICMJE
MLA
NLM
Villa, L. L., Perez, G., Kjaer, S. K., Paavonen, J., Lehtinen, M., Muñoz, N., … Sviggum, O. (2007). Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey, 62(9), 578–579. https://doi.org/10.1097/01.ogx.0000280190.01879.f9
Villa, L. L., G. Perez, S. K. Kjaer, J. Paavonen, M. Lehtinen, N. Muñoz, K. Sigurdsson, et al. “Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.” Obstetrical and Gynecological Survey 62, no. 9 (September 1, 2007): 578–79. https://doi.org/10.1097/01.ogx.0000280190.01879.f9.
Villa LL, Perez G, Kjaer SK, Paavonen J, Lehtinen M, Muñoz N, et al. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey. 2007 Sep 1;62(9):578–9.
Villa, L. L., et al. “Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.” Obstetrical and Gynecological Survey, vol. 62, no. 9, Sept. 2007, pp. 578–79. Scopus, doi:10.1097/01.ogx.0000280190.01879.f9.
Villa LL, Perez G, Kjaer SK, Paavonen J, Lehtinen M, Muñoz N, Sigurdsson K, Hernandez-Avila M, Skjeldestad FE, Thoresen S, García P, Majewski S, Dillner J, Olsson SE, Tay EH, Xavier Bosch F, Ault KA, Brown DR, Ferris DG, Koutsky LA, Kurman RJ, Myers ER, Barr E, Boslego J, Bryan J, Esser MT, Gause CK, Hesley TM, Lupinacci LC, Sings HL, Taddeo FJ, Thornton AR, Boulos M, Cox JT, Langmark F, Modlin J, Muñoz A, Odlind V, Wilkinson E, Ferenczy A, Kurman R, Ronnett B, Stoler M, Andreoni G, Bahamondes L, Camargos A, Costa R, De Andrade R, Fedrizzi E, Ferriani R, Gonçalves M, Laginha F, Mendonça J, Moreira E, Nonnenmacher B, Taborda W, Zanetta D, Ardila J, Balcazar N, Maldonado I, Revollo F, Ruiz A, Andersen ES, Djursing H, Hansen T, Jørgensen JJ, Nilas L, Ottesen B, Petersen LK, Thomsen SG, Toftager-Larsen K, Apter D, Kekki M, Kuortti M, Lahti L, Lindroos Y, Lunnas T, Palmroth J, Lazcano E, Zertuche J, Dalaker K, Eriksen B, Ernø LE, Fiane B, Hesla K, Myhre Isachsen M, Iversen OE, Kasin K, Kristoffersen M, Lunde T, Nordmark PT, Nygaard T, Onsrud M, Riis-Johannessen G, Schiøtz H, Sundhagen H, Sviggum O. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. Obstetrical and Gynecological Survey. 2007 Sep 1;62(9):578–579.
Published In
Obstetrical and Gynecological Survey
DOI
ISSN
0029-7828
Publication Date
September 1, 2007
Volume
62
Issue
9
Start / End Page
578 / 579
Related Subject Headings
- Obstetrics & Reproductive Medicine
- 4204 Midwifery
- 3215 Reproductive medicine
- 1114 Paediatrics and Reproductive Medicine